Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: December 8, 2010

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Dulera	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Vimovo	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Bromday	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Creon DR	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Onglyza	New Drug Appeal	Remove Prior Approval Requirement	Require Prior Approval
Adcirca	New Drug Appeal	Preferred with Prior Approval Required	Preferred with Prior Approval Required

Footer